On ECHEMI
Home > Drugs > Yulin Lijun Pharmaceutical Co., Ltd.
Yulin Lijun Pharmaceutical Co., Ltd.
  • Founded in:

    2010-01-11
  • Country:

    China China
  • Address:

    No. 1, Shimao Road, Mahuangliang Industrial Park, Yuyang District, Yulin City, Shaanxi Province
  • Tax NO.:

    916108006984228963
  • Registered Funds:

    20 million yuan
  • Email:

Related Drugs
Trimethoprim Tablets
Trimethoprim
Name Description Content CAS NO. Registered Holders
Trimethoprim

Trimethoprim (TMP) is an antibacterial agent, a lipophilic weak base, and its chemical structure belongs to the pyrimethamine class. It has antibacterial activity against Escherichia coli, Klebsiella, Proteus mirabilis, Salmonella, and Shigella, but has no obvious antibacterial effect on Streptococcus pneumoniae, Neisseria gonorrhoeae, and Neisseria meningitidis, and has no effect on Pseudomonas aeruginosa. The mechanism of action of this product is to interfere with bacterial folic acid metabolism. It mainly selectively inhibits the activity of bacterial dihydrofolate reductase, so that dihydrofolate cannot be reduced to tetrahydrofolate, and synthetic folic acid is the main component of nucleic acid biosynthesis. Therefore, this product prevents the synthesis of bacterial nucleic acids and proteins, and the binding of this product to bacterial dihydrofolate reductase is 50,000 to 60,000 times tighter than that to mammalian enzymes. The combination of this product and sulfonamides can double block the bacterial folic acid synthesis metabolism, have a synergistic effect, enhance the antibacterial activity of sulfonamides, and convert the antibacterial effect into a bactericidal effect, reducing the production of drug-resistant strains.

More

Trimethoprim (TMP) is an antibacterial agent, a lipophilic weak base, and its chemical structure belongs to the pyrimethamine class. It has antibacterial activity against Escherichia coli, Klebsiella, Proteus mirabilis, Salmonella, and Shigella, but has no obvious antibacterial effect on Streptococcus pneumoniae, Neisseria gonorrhoeae, and Neisseria meningitidis, and has no effect on Pseudomonas aeruginosa. The mechanism of action of this product is to interfere with bacterial folic acid metabolism. It mainly selectively inhibits the activity of bacterial dihydrofolate reductase, so that dihydrofolate cannot be reduced to tetrahydrofolate, and synthetic folic acid is the main component of nucleic acid biosynthesis. Therefore, this product prevents the synthesis of bacterial nucleic acids and proteins, and the binding of this product to bacterial dihydrofolate reductase is 50,000 to 60,000 times tighter than that to mammalian enzymes. The combination of this product and sulfonamides can double block the bacterial folic acid synthesis metabolism, have a synergistic effect, enhance the antibacterial activity of sulfonamides, and convert the antibacterial effect into a bactericidal effect, reducing the production of drug-resistant strains.

738-70-5 44
Cough Dew
Ephedra, Aster, Licorice, Bitter Almond, etc.
Name Description Content CAS NO. Registered Holders
Ephedra

Cough and phlegm

More

Cough and phlegm

0
Asters

Cough and phlegm

More

Cough and phlegm

0
DGL

Cough and phlegm

More

Cough and phlegm

0
ARMENIACAE SEMEN AMARUM

Cough and phlegm

More

Cough and phlegm

0
Reduping Granule
Gypsum, honeysuckle, Scrophularia, Rehmannia, Forsythia, Gardenia, Sweet Peony, Scutellaria, Gentiana, Isatis, Anemarrhena, Ophiopogon.
Name Description Content CAS NO. Registered Holders
Calcium sulfate dihydrate

10101-41-4 0
LONICERAE JAPONICAE FLOS

0
Scrophulariae Radix

0
REHMANNIAE RADIX PRAEPARATA

0
Forsythiae Fructus

0
Gardeniae Fructus

0
sweet diced

0
RADIX SCUTELLARIAE

0
Borneol

507-70-0 1
Isatidis Radix

0
ANEMARRHENAE RHIZOMA

0
Ophiopogonis Radix

0
Glycyrrhizic acid monopotassium salt tablets
Glycyrrhizic acid monopotassium salt.
Name Description Content CAS NO. Registered Holders
Monopotassium glycyrrhizate

Not yet clear

More

Not yet clear

42294-03-1 2
Compound Ammonium Glycyrrhizinate Injection
This product is a compound preparation. Its components are: each vial contains 4mg of ammonium glycyrrhizinate, 40mg of glycine, and 3mg of L-cysteine hydrochloride. The auxiliary materials are anhydrous sodium sulfite and sodium chloride.
Name Description Content CAS NO. Registered Holders
Glycyrrhizic acid ammonium salt

4mg 53956-04-0 8
Glycine

40mg 56-40-6 27
L-Cysteine monohydrochloride

3mg 52-89-1 10
Sodium sulfite

7757-83-7 10
Sodium chloride

7647-14-5 43
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.